Prometheus Pushes Fed. Circ. To Revive IBS Drug Patent
Prometheus Laboratories Inc. urged a Federal Circuit panel Tuesday to bring back its patent for a drug that treats certain irritable bowel syndrome patients, saying an obviousness finding could chill the...To view the full article, register now.
Already a subscriber? Click here to view full article